Compound 3f Chemical Structure oral Factor XIa inhibitor - Janssen Research & Development, L.L.C., Spring House, PA

oral Factor XIa inhibitor

IV efficacy in rabbit AV shunt model

from literature starting point and SBDD

J. Med. Chem.

Janssen Research & Development, L.L.C., Spring House, PA

Context. “Compound 3f” (Janssen) is an oral Factor XIa (FXIa) inhibitor being developed for thromboembolic diseases. The suitability of FXIa as a target in the development of anticoagulation agents…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.